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2Department of Medicine, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OhioTo the Editor:
LeMaistre and coworkers [1] are to be congratulated for
deﬁning and clarifying many terms describing procedures
used in the context of hematopoietic cell transplantations.
We submit, however, that they may have erred by referring
to infusing or transplanting hematopoietic cells as a “hema-
topoietic stem cell infusion” or “hematopoietic stem cell
transplantation.”What convincing scientiﬁc data or evidence
have they that the products practitioners infuse or transplant
are indeed “stem” cells? None. We and others have discussed
widespread confusion and inappropriate use of the term
“stem” cell in a clinical context [2-5]. What we know, but
only in persons carefully studied postinfusion or post-
transplantation, is the genetic relationship between the
donor and subsequent hematopoietic cells. Precisely from
where these postinfusion or post-transplantation cells orig-
inate, a stem cell, a pluripotent cell(s), a multipotent cell(s),
a committed cell(s), or some other cell(s), is unknown and, in
most clinical circumstances, unknowable. Also, the answerFinancial disclosure: See Acknowledgments on page 1656.
* Correspondence and reprint requests: Robert Peter Gale, M.D., Ph.D.,
11693 San Vicente Boulevard, Suite 335, Los Angeles, CA 90049.
E-mail address: robertgalemd@gmail.com (R.P. Gale).
1083-8791/$ e see front matter  2013 American Society for Blood and Marrow
http://dx.doi.org/10.1016/j.bbmt.2013.06.018may differ in different persons and in a person at different
times postinfusion or post-transplantation. Because of these
considerations, we recommend using “hematopoietic cell
infusion” or “hematopoietic cell transplantation,” which
makes no claim beyond what we can prove and which is
unlikely to be incorrect.ACKNOWLEDGMENTS
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